Navigation Links
Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
Date:1/5/2009

for the accreditation of hospitals, and the Institute for Safe Medication Practices. Providing injectable products, especially those for critical care use, in premixed, ready to use forms is a high priority solution to minimize medication errors.

Dr. Cooper continued, "While this regulatory approval is for NEXTERONE supplied in vials and a prefilled syringe, the changes in the compatibility and stability profile of NEXTERONE, brought about by the removal of polysorbate 80 and benzyl alcohol, present the opportunity to formulate intravenous amiodarone for the first time in premixed, ready to use configurations."

Prism is currently implementing a full scale manufacturing development program with the Medication Delivery business of Baxter Healthcare Corporation, a world leader in premix technologies. Prism intends to submit a supplemental NDA for the premixed configurations which will form the focus of the commercial launch of NEXTERONE as a complete product line. Health-System Pharmacists hold the primary management responsibility for improvements in medication safety in hospitals and this will be a key target customer group for NEXTERONE.

"We intend to commercialize NEXTERONE ourselves in the US with partners that are well positioned in the hospital marketplace and will seek to license the ex-US worldwide rights," said Dr. Cooper. "As we round out the NEXTERONE product line with the premixed bag configurations, we are concurrently defining the best approach to launch the brand, drive rapid conversion and optimize the value of NEXTERONE to pharmacists, clinicians, patients and the Company. I believe NEXTERONE can rapidly replace generic Amiodarone IV when it becomes available and has the potential to eventually render conventional Amiodarone IV obsolete."

The FDA approval of NEXTERONE triggers a second $10M milestone payment from Paul Capital. This long range financing agreement, estab
'/>"/>

SOURCE Prism Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
2. New Empire BlueCross BlueShield Prism Plans Offer Better Choice and Affordability for New York Small Group Market
3. Prism glasses expand the view for patients with hemianopia
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... The National Quality Forum’s (NQF) Board ... for a defined period that will assess the ... measures for sociodemographic factors, prior to making a ... can be socioeconomic, e.g., income, education, and occupation, ... Growing evidence shows that sociodemographic factors may ...
(Date:7/23/2014)... 23, 2014 In preparation for National ... Millennium Treatment Group is providing tips on choosing a ... society ever since man first figured out the process ... has existed since shortly thereafter. Its basis lies in ... then developing a way to combat that problem while ...
(Date:7/23/2014)... Steven Reinberg HealthDay ... -- Many obese and overweight American children and teens ... is fine, U.S. health officials reported Wednesday. "Being ... such as high blood pressure, high cholesterol and diabetes," ... the U.S. Centers for Disease Control and Prevention,s National ...
(Date:7/23/2014)... Inventor and entrepreneur Delegate Joe T. ... the gas pump – sharing his passion for technology ... at Noon. , With 24 patents granted and three ... anyone in the General Assembly since Thomas Jefferson. Inventions ... marker as seen on television, an instrument for measuring ...
(Date:7/23/2014)... WHAT: The National Institute of Biomedical Imaging and ... Investigator Symposium on July 30, 2014 on the NIH ... new investigators covering a wide breadth of NIBIB-funded research. ... Adam Cohen, Harvard, Engineering Microbial Rhodopsins as Optical Voltage ... Testing Fluorescently Labeled Probes for Nerve ...
Breaking Medicine News(10 mins):Health News:NQF Board Approves Trial Period to Test Impact of Risk Adjustment of Performance Measures for Sociodemographic Factors 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 3Health News:Celebrating Innovation and Invention 2
... UK, US and Canada are undermining tobacco prevention campaigns by ... public health researchers says. The paper, published in the open ... tobacco imagery should be ineligible for public funding to ensure ... goals. Earlier research shows that young people who are ...
... Aug. 23 (HealthDay News) -- Researchers say boys are ... that males have been reaching sexual maturity about 2.5 ... "The reason for earlier maturity for ... disease environments are getting more favorable for it," demographer ...
... 2011 In a joint research effort with researchers ... from scientists at The University of Pennsylvania, The University ... from the Florida campus of The Scripps Research Institute ... to rid themselves of damaged mitochondria, which are the ...
... in a new study a different approach to predict ... other similar chemicals. For many chemicals in ... to understand all of the effects on the environment ... Union enacted the REACH regulation, which places greater responsibility ...
... the University of Toronto,s psychology department show that ... Botox injections or surgery are viewed more negatively than ... facial creams and younger adults are more negative about ... suggest that despite the rapid growth of the anti-aging ...
... most frequent type of malignant brain tumor in children. Ependymoma ... hollow cavities of the brain. Therapy results of ependymoma vary ... standstill after surgery and radiotherapy, in other children the disease ... affected the tumor continues to grow and the patients often ...
Cached Medicine News:Health News:Government subsidies to the US film industry promote youth smoking, argue researchers 2Health News:Boys Mature Sexually Earlier Than Ever Before: Study 2Health News:Scripps Research scientists define cellular pathway essential to removing damaged mitochondria 2Health News:Scientists develop new approaches to predict the environmental safety of chemicals 2Health News:U of T research shows anti-aging techniques not yet viewed as acceptable 2Health News:Brain tumors found to have a 2-tier system 2
(Date:7/23/2014)... 23, 2014 Research and Markets ... Gloves (Exam and Surgical) Markets Worldwide 2014" report ... The purpose of this report is ... Medical (Exam and Surgical) Gloves. The report discusses key ... products. Topics covered include product definitions, strategies, ...
(Date:7/23/2014)... , July 23, 2014  Lightlake Therapeutics Inc. ... treatments based on its expertise in opioid antagonists, ... new drug application ("IND") with respect to its ... announced today that it has received an additional ... ("NIDA"), part of the National Institutes of Health ...
(Date:7/23/2014)... , July 23, 2014 This September leading ... Las Vegas for DOCtalk ... educator, author, forward thinker and private practitioner Dr. ... together to candidly discuss clinical and practice management efficiency ... is a unique opportunity to welcome fresh thinking and ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 32014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... BURLINGTON, Vt ., June 4 Mach 7 Technologies ... has relocated its global headquarters from suburban Chicago to ... the company,s base for Americas, sales and professional service operations, and ... and strategic R&D functions. , ...
... June 4 /PRNewswire-Asia-FirstCall/ -- Jiangbo,Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) ... China , today,announced that the Company has received approval to list its ... , , ... will begin trading on the NASDAQ,Global Market on Tuesday, June 8, ...
Cached Medicine Technology:Mach 7 Technologies Establishes New Headquarters in Burlington, VT 2Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market 2Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market 3
Round handle colibri tying forceps with 5 mm titanium coated platforms. Length 100 mm....
Barraquer straight tying forceps....
Round handle curved tying forceps with 5 mm titanium coated platforms. Length 110 mm....
Colibri tying forceps with 5 mm titanium coated platforms. Length 85 mm....
Medicine Products: